Breakthrough Nanovaccine Targets HPV-Related Cancers A novel nanovaccine designed to combat cancers driven by the human papillomavirus (HPV) has demonstrated remarkable effectiveness in an animal model of late-stage metastatic disease. Developed by researchers at UT Southwestern Medical Center, the study highlights a promising approach that could shift the treatment landscape for HPV-associated malignancies, which include…